-
2019’s medtech industry to weigh hype and realism in equal parts
fiercebiotech
December 25, 2018
Heading into 2019, the medtech industry is, in some ways, the strongest it’s ever been—though its players may see new challenges in trying to balance hype and scientific promise against cold reality and economics....
-
Imperial and Bayer to use AI for heart conditions
pharmatimes
December 24, 2018
Researchers at Imperial and Bayer Pharmaceuticals are partnering up to explore how artificial intelligence (AI) can be used to accelerate the discovery of new drugs for heart conditions.
-
FDA grants breakthrough device designation to artificial intelligence software for CTEPH pattern recognition from Bayer and MSD
worldpharmanews
December 06, 2018
Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pattern Recognition...
-
Sanofi merges biology and tech with research deal for digital asthma lab
fiercepharma
December 06, 2018
Sanofi plans to take asthma research where it has not gone before. A new partnership with Mount Sinai Health System and advanced analytics firm Sema4 will create a digital asthma
-
Fusion Antibodies and Analytics Engines to Incorporate Artificial Intelligence into Its World Class Antibody Humanization Service
pharmafocusasia
November 26, 2018
Fusion Antibodies plc, experts in antibody engineering and Analytics Engines, an advanced data analytics company, have announced a strategic collaboration to incorporate machine learning (ML) and artificial intelligence (AI) into Fusion Antibodies’ CDRx™
-
Klue adds insulin reminders to behavioral change AI platform
fiercebiotech
November 05, 2018
Klue seeks to change behaviors for the better through an artificial intelligence platform that works with wearables, such as a smartwatch...
-
AI drug miner XtalPi raises another $46M in series B add-on
fiercebiotech
November 02, 2018
Chinese AI drug discovery startup XtalPi has raised another $46 million this year, in an extension of its venture capital round, to finance expansion of its computerized pharmaceutical research platform.
-
AI drug discovery platform gets £1m innovation boost
pharmatimes
September 20, 2018
Innovate UK is streaming funds into a £1-million artificial intelligence (AI) research project to be delivered by the Medicines...
-
TraceLink $93 million investment to accelerate expansion of information-sharing network platform
cphi-online
August 23, 2018
Investment will fuel the digitalization of the global pharmaceutical supply chain through the integration of real-time information-sharing, to create a highly predictable supply chain for the industry.
-
NUS scientists develop new technology to treat myeloma patients
biospectrumasia
August 15, 2018
With just a small amount of blood or bone marrow sample from patients, the platform is able to map the drug response that a set of drug combinations will have on the specific patient's cancer cells.